Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Retina (Philadelphia, Pa.)
|
March 20, 2013
Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results
Robert Petrarca, Matthew Richardson, Abdel Douiri, et al.
Ophthalmology
|
April 3, 2012
Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE study: twelve-month safety and efficacy results
Pravin U Dugel, Robert Petrarca, Michael Bennett, et al.
Retina (Philadelphia, Pa.)
|
October 31, 2013
Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 24 safety and efficacy results
Robert Petrarca, Pravin U Dugel, Michael Bennett, et al.
American Journal of Ophthalmology
|
June 5, 2007
Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study
Esen Karamursel Akpek, Mona Harissi-Dagher, Robert Petrarca, et al.
Ocular Immunology and Inflammation
|
April 2, 2008
Atypical Bartonella hensalae chorioretinitis in an immunocompromised patient
Sayjal J Patel, Robert Petrarca, Syed Mahmood Shah, et al.
Ophthalmology
|
March 16, 2013
Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography
Timothy L Jackson, Pravin U Dugel, Judith D Bebchuk, et al.
JAMA Ophthalmology
|
July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial
Timothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Ophthalmology
|
April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial
Timothy L Jackson, Riti Desai, Andrew Simpson, et al.
The British Journal of Ophthalmology
|
February 26, 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial
Timothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Retina (Philadelphia, Pa.)
|
March 20, 2013
Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results
Robert Petrarca, Matthew Richardson, Abdel Douiri, et al.
Ophthalmology
|
April 3, 2012
Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE study: twelve-month safety and efficacy results
Pravin U Dugel, Robert Petrarca, Michael Bennett, et al.
Retina (Philadelphia, Pa.)
|
October 31, 2013
Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 24 safety and efficacy results
Robert Petrarca, Pravin U Dugel, Michael Bennett, et al.
American Journal of Ophthalmology
|
June 5, 2007
Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study
Esen Karamursel Akpek, Mona Harissi-Dagher, Robert Petrarca, et al.
Ocular Immunology and Inflammation
|
April 2, 2008
Atypical Bartonella hensalae chorioretinitis in an immunocompromised patient
Sayjal J Patel, Robert Petrarca, Syed Mahmood Shah, et al.
Ophthalmology
|
March 16, 2013
Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography
Timothy L Jackson, Pravin U Dugel, Judith D Bebchuk, et al.
JAMA Ophthalmology
|
July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial
Timothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Ophthalmology
|
April 18, 2016
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial
Timothy L Jackson, Riti Desai, Andrew Simpson, et al.
The British Journal of Ophthalmology
|
February 26, 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial
Timothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Page
of 2